This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
stock-price-movement: Archive
Strength Seen in Sleep Number (SNBR): Can Its 19.1% Jump Turn into More Strength?
by Zacks Equity Research
Sleep Number (SNBR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
SNBRNegative Net Change LEGNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Tri Pointe (TPH) Moves 5.9% Higher: Will This Strength Last?
by Zacks Equity Research
Tri Pointe (TPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
TPHPositive Net Change DFHPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Skyline (SKY): Can Its 6.2% Jump Turn into More Strength?
by Zacks Equity Research
Skyline (SKY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
SKYPositive Net Change PATKNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
International Money Express (IMXI) Soars 5.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
International Money Express (IMXI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
IMXIPositive Net Change FISNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
All You Need to Know About Griffon (GFF) Rating Upgrade to Strong Buy
by Zacks Equity Research
Griffon (GFF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
GFFNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Brixmor (BRX) Rating Upgrade to Buy
by Zacks Equity Research
Brixmor (BRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BRXNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Block (SQ) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Block (SQ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SQPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Equinix (EQIX) Rating Upgrade to Buy
by Zacks Equity Research
Equinix (EQIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
EQIXNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Beyond Air (XAIR) Rating Upgrade to Strong Buy
by Zacks Equity Research
Beyond Air (XAIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
XAIRPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Integral Ad Science (IAS) Upgraded to Buy: Here's Why
by Zacks Equity Research
Integral Ad Science (IAS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
IASPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Arcadia Biosciences (RKDA) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Arcadia Biosciences (RKDA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
RKDANegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Workday (WDAY) a New Buy Stock
by Zacks Equity Research
Workday (WDAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
WDAYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
SilverCrest Metals (SILV) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
SilverCrest Metals (SILV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
SILVNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes CochLear Ltd. Unsponsored ADR (CHEOY) a New Buy Stock
by Zacks Equity Research
CochLear Ltd. Unsponsored ADR (CHEOY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CHEOYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Eventbrite (EB) Soars 22.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Eventbrite (EB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EBNegative Net Change DASHPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in OSI (OSIS): Can Its 3.2% Jump Turn into More Strength?
by Zacks Equity Research
OSI (OSIS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
OSISNegative Net Change ALNTNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Shopify (SHOP) Moves 8.6% Higher: Will This Strength Last?
by Zacks Equity Research
Shopify (SHOP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
SHOPPositive Net Change TTDPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Moog (MOG.A): Can Its 5.4% Jump Turn into More Strength?
by Zacks Equity Research
Moog (MOG.A) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MOG.ANegative Net Change ASLENegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Should You Buy Amplify Energy (AMPY) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
AMPYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Here's Why Brinker International (EAT) Is a Great 'Buy the Bottom' Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Brinker International (EAT), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
EATPositive Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
Royalty Pharma (RPRX) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
RPRXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Fastly (FSLY) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
FSLYNo Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Spire (SPIR) Moves 9.0% Higher: Will This Strength Last?
by Zacks Equity Research
Spire (SPIR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SPIRPositive Net Change RDWNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in ICF (ICFI): Can Its 3.6% Jump Turn into More Strength?
by Zacks Equity Research
ICF (ICFI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ICFINo Net Change MMSNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Recent Price Trend in Graham (GHM) is Your Friend, Here's Why
by Zacks Equity Research
Graham (GHM) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
GHMPositive Net Change
price-performance stock-price-change stock-price-movement